High Percentage of CD34-positive Cells in Autologous AML Peripheral Blood Stem Cell Products Reflects Inadequate in Vivo Purging and Low Chemotherapeutic Toxicity in a Subgroup of Patients With Poor Clinical Outcome

Leukemia - United Kingdom
doi 10.1038/sj.leu.2402781

Related search